Details for New Drug Application (NDA): 202801
✉ Email this page to a colleague
The generic ingredient in LEVOFLOXACIN is levofloxacin. There are thirty-one drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levofloxacin profile page.
Summary for 202801
Tradename: | LEVOFLOXACIN |
Applicant: | Hetero Labs Ltd V |
Ingredient: | levofloxacin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202801
Suppliers and Packaging for NDA: 202801
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEVOFLOXACIN | levofloxacin | TABLET;ORAL | 202801 | ANDA | Camber Pharmaceuticals, Inc. | 31722-721 | 31722-721-31 | 10 TABLET, FILM COATED in 1 BLISTER PACK (31722-721-31) |
LEVOFLOXACIN | levofloxacin | TABLET;ORAL | 202801 | ANDA | Camber Pharmaceuticals, Inc. | 31722-721 | 31722-721-32 | 100 TABLET, FILM COATED in 1 BLISTER PACK (31722-721-32) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | Jan 8, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
Approval Date: | Jan 8, 2015 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 750MG | ||||
Approval Date: | Jan 8, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription